LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors
Back to library search

A Path Through the Forest - The Role of Agency Guidance in Developing Regulatory Compliance Programs

February 2014CompliancePharmaceutical

Abstract

Counsel involved in developing regulatory compliance programs know that merely looking at the statute and regulations is not enough. They need to look to multiple sources of information to determine how the agency interprets the laws and regulations, and to understand agency expectations. Agency guidance documents play an important role in obtaining this information. This paper identifies the types of materials available and how they can be used. It also touches on the problems with these materials, including their nonbinding nature, and the benefits of using them.

Subscribe to reador
PLS Logo Copyright & permissions

Author

Jack Sorokin

Adjunct Instructor, Fremont College, USA

Related Papers

“Crisis-Capable Compliance: The CCO at the Crossroads of AI, Ethics, and Leadership”
The role of the Chief Compliance Officer is undergoing a fundamental transformation in the era of artificial intelligence. No longer confined to oversight and enforcement, the CCO is emerging as...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Dolores Guzman
Dolores Guzman
Legal & Compliance Director, Apex America, UK
Implementing Effective Compliance Programs in Jurisdictions Where the Rule of Law is Weak
Multinational organizations increasingly operate in jurisdictions where the rule of law is weak, inconsistently enforced, or subject to political and economic influence. For pharmaceutical and biotechnology companies, these environments present...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Valentina Lacerca-Allen
Valentina Lacerca-Allen
Title Marketing/ Communication Specialist, Ethiprax LLC., USA
The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer's Perspective
The intersection between the health care fraud and abuse laws and pharmaceutical marketing practices in the U.S. raises interesting compliance issues for pharmaceutical manufacturers, particularly in light of the newly...Read more
Portrait image of Leslie Restaino
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
The Perception Risk Vector: Why Optics Matter and How to Manage it in Corporate Compliance
Oftentimes “how it looks” can be as damaging as “what happened.” For regulators, prosecutors, courts, employees, customers, investors, and investigative journalists, organizational ethics is never judged solely through the narrow...Read more
Portrait image of Camélia Gardot
Camélia Gardot
Senior Director of Compliance, Hertz, France